title: [Changing epidemiological aspects of candidemia and their clinical and therapeutic implications].
abstract: Candida species are a major cause of healthcare-related bloodstream and invasive infections. Studies assessing nosocomial bloodstream infections during the two last decades ranked Candida species as the fourth most common nosocomial bloodstream pathogen. The incidence of Candida species has risen steadily during this period due to the increase in the number and type of patients at risk for these yeasts. Infections caused by Candida are especially frequent and serious in onco-hematological patients. Over the past decade, the introduction of azole antifungals as prophylactic agents, together with other factors, has led to a shift in the species of Candida that cause infection. During the period under review (1996 to 2005) several studies have confirmed the impact of antifungal prophylaxis with azoles on the emergence of Candida species other than Candida albicans. The widespread use of fluconazole has contributed to a relative decrease in the prevalence of C. albicans, while species inherently less susceptible, such as Candida glabrata and Candida krusei, appear to be isolated with greater frequency. Moreover, laboratory studies to determine the antifungal susceptibilities and virulence of non-albicans Candida species have enabled the design of microbe-specific management strategies. More of these studies will be necessary as we enter an age in which multiple antifungal compounds (echinocandins, new azoles) will become available for clinical use in invasive candidiasis or candidemia. The present review aims to highlight the different trends in the incidence, distribution and behavior of Candida bloodstream infections in the distinct types of patients at risk.
authors.affiliation: Unidad de Enfermedades Infecciosas, Hospital Universitario La Fe, Valencia, España. salavert_mig@gva.es
authors.forename: Miguel
authors.initials: M
authors.lastname: Salavert Lletí
authors.forename: Isidro
authors.initials: I
authors.lastname: Jarque Ramos
authors.forename: Javier
authors.initials: J
authors.lastname: Pemán García
mesh_terms: D058387:Candidemia / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology; D006801:Humans; D012307:Risk Factors